Article Sidebar

PDF
Date Published: 26/04/2022
Abstract Views: 712
Views PDF: 365
DOI: https://doi.org/10.51298/vmj.v512i2.2264
Issue
Vol. 512 No. 2 (2022)
Section
Các bài báo
How to Cite
Công Long, N. ., & Thanh Nam, N. (2022). EVALUATED ON CLINICAL FEATURE, SUB-CLINICAL OF NONALCOHOLIC FATTY LIVER DISEASE. Vietnam Medical Journal, 512(2). https://doi.org/10.51298/vmj.v512i2.2264

EVALUATED ON CLINICAL FEATURE, SUB-CLINICAL OF NONALCOHOLIC FATTY LIVER DISEASE

Nguyễn Công Long1,, Nguyễn Thanh Nam1
1 Department of Gastroenterology and Hepatology, Bach Mai Hospital

Main Article Content

Abstract

Objectives: The aim of this study was the evaluation of clinical features and subclinical of nonalcoholic fatty liver disease (NAFLD) Method: A total of 50 patients were enrolled with nonalcoholic fatty liver disease from 01/2019 to7/2020 in Bachmai hospital. Results: Mean age at diagnosis was 47 years, 23(45.1%) were male. Common clinical symptoms are fatigue, dyspepsia, abdomial pain accounted for 58.8%), 35.3% and 13.7%, respectively. 100% of patients had very high elevation of alanine aminotransferase (ALT), aspartate aminotransferase (AST) and GGT. In addition, the majority of patients had metabolic syndrome such as Hypertriglyceridemia (80%) and low HDL (8%). The diabetes rate was 13.7%. Conclusion: diagnosed NAFLD patients is higher in young age. The most common symptoms is fatigue and elevated aminotransferase.

Article Details

Keywords

NAFLD, NASH

References

1. Anstee, Q.M., et al., From NASH to HCC: current concepts and future challenges. Nat Rev Gastroenterol Hepatol, 2019. 16(7): p. 411-428.
2. Wong, V.W. and H.L. Chan, Transient elastography. J Gastroenterol Hepatol, 2010. 25(11): p. 1726-31.
3. Saydah, S.H., et al., Abnormal glucose tolerance and the risk of cancer death in the United States. Am J Epidemiol, 2003. 157(12): p. 1092-100.
4. Ioannou, G.N., et al., Is obesity a risk factor for cirrhosis-related death or hospitalization? A population-based cohort study. Gastroenterology, 2003. 125(4): p. 1053-9.
5. Malik, S., et al., Impact of the metabolic syndrome on mortality from coronary heart disease, cardiovascular disease, and all causes in United States adults. Circulation, 2004. 110(10): p. 1245-50.
6. Eriksson, K.F. and F. Lindgärde, No excess 12-year mortality in men with impaired glucose tolerance who participated in the Malmö Preventive Trial with diet and exercise. Diabetologia, 1998. 41(9): p. 1010-6.